Ngm Biopharmaceuticals shares owned by Euclidean Capital
Quarter-by-quarter ownership of Ngm Biopharmaceuticals (NGM) shares owned by Euclidean Capital
from 13F filings
Historical chart of Euclidean Capital investment in Ngm Biopharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Ngm Biopharmaceuticals held by Euclidean Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ngm Biopharmaceuticals by Euclidean Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $852k | 992k | 0.86 |
| 2023-09-30 | $1.1M | 992k | 1.07 |
| 2023-06-30 | $1.9M | 747k | 2.59 |
| 2023-03-31 | $3.0M | 747k | 4.08 |
| 2022-12-31 | $3.7M | 747k | 5.02 |
| 2022-09-30 | $9.8M | 747k | 13.08 |
| 2022-06-30 | $9.6M | 747k | 12.82 |
| 2022-03-31 | $11M | 747k | 15.25 |
| 2021-12-31 | $13M | 747k | 17.71 |
| 2021-09-30 | $18M | 832k | 21.02 |
| 2021-06-30 | $29M | 1.5M | 19.72 |
| 2021-03-31 | $43M | 1.5M | 29.07 |
| 2020-12-31 | $63M | 2.1M | 30.30 |